Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis Vulgaris 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Probiotics × Clear all
NCT05254249 2022-02-24

Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris

Dr. Soetomo General Hospital

Phase 1/2 Unknown
75 enrolled

Psoriasis Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon âš¡